Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study Lei Li*, XinXin Kou, XiaoJie Feng, MingChuan Zhang, HongTu Chao and LiYing Wang Background: This study assessed the survival outcomes and recurrent patterns in pelvic node-positive IB1-IIA2 cervical cancer patients treated with postoperative external beam irradiation with or without vaginal brachytherapy. Methods: The records of 1149 cervical cancer patients received radical surgery between February 2008 and March 2010 were retrospectively reviewed. 126 stages IB1-IIA2 patients with positive pelvic lymph node (LN) were included and a total of 113 patients who received different post...
Objective: The aim of this study was to determine possible impact of routinely scheduled biopsies an...
BACKGROUND: After surgery for intermediate-risk endometrial carcinoma, the vagina is the most freque...
Abstract Background For stage I to II high-risk endometrioid adenocarcinoma patients, the optimal ad...
ObjectiveThe aim of this study was to assess the impact of the evolving role of the addition of chem...
Objective There are a limited number of studies supporting vaginal brachytherapy boost to external b...
ObjectiveTo explore the suitable cases for vaginal cuff brachytherapy (VCB) combined with external b...
PURPOSE: Adjuvant treatment in early stage uterine serous carcinoma (USC) usually consists of chemot...
PURPOSE: Adjuvant treatment in early stage uterine serous carcinoma (USC) usually consists of chemot...
BACKGROUND: After radical hysterectomy and pelvic lymph node dissection, an identifiable subgroup of...
Background: The objective of the present study was to optimize the role of adjuvant radiotherapy in ...
Abstract Background Current recommendation for locally advanced cervical cancer includes pelvic exte...
AbstractPurpose/Objectives: To analyze the correlation between size of lymph node and these control ...
ObjectiveThe role of salvage radiotherapy (RT) in the treatment for vaginal recurrence of cervical c...
Objective: Multiple treatment options are used in early local-stage cervical cancer, including combi...
Objective. The aim of this study is to investigate the impact of treatment policy changes in cervica...
Objective: The aim of this study was to determine possible impact of routinely scheduled biopsies an...
BACKGROUND: After surgery for intermediate-risk endometrial carcinoma, the vagina is the most freque...
Abstract Background For stage I to II high-risk endometrioid adenocarcinoma patients, the optimal ad...
ObjectiveThe aim of this study was to assess the impact of the evolving role of the addition of chem...
Objective There are a limited number of studies supporting vaginal brachytherapy boost to external b...
ObjectiveTo explore the suitable cases for vaginal cuff brachytherapy (VCB) combined with external b...
PURPOSE: Adjuvant treatment in early stage uterine serous carcinoma (USC) usually consists of chemot...
PURPOSE: Adjuvant treatment in early stage uterine serous carcinoma (USC) usually consists of chemot...
BACKGROUND: After radical hysterectomy and pelvic lymph node dissection, an identifiable subgroup of...
Background: The objective of the present study was to optimize the role of adjuvant radiotherapy in ...
Abstract Background Current recommendation for locally advanced cervical cancer includes pelvic exte...
AbstractPurpose/Objectives: To analyze the correlation between size of lymph node and these control ...
ObjectiveThe role of salvage radiotherapy (RT) in the treatment for vaginal recurrence of cervical c...
Objective: Multiple treatment options are used in early local-stage cervical cancer, including combi...
Objective. The aim of this study is to investigate the impact of treatment policy changes in cervica...
Objective: The aim of this study was to determine possible impact of routinely scheduled biopsies an...
BACKGROUND: After surgery for intermediate-risk endometrial carcinoma, the vagina is the most freque...
Abstract Background For stage I to II high-risk endometrioid adenocarcinoma patients, the optimal ad...